RHHBY ROCHE HOLDING AG
- 29.830
- +0.570+1.95%
ROCHE HOLDING AG News
UBS Sticks to Their Hold Rating for Roche Holding AG (RHHVF)
Regeneron Falls After Q1 Miss; Announces $3B Share Buybacks
European Medicines Agency Committee Backs Roche's Subcutaneous Injection for Multiple Sclerosis
Roche (RO.SW, ROG.SW) said Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the approval of Ocrevus subcutaneous injection for multiple sclerosis
J&J, Roche, AstraZeneca Poised to Have Highest Orphan Drug Sales by End of Decade
Phase 3 clinical trial of Roche (RHHBY.US) major antibody therapy Ocrevus obtained positive data
Recently, Genetech, a subsidiary of Roche (RHHBY.US), announced that its major antibody therapy ORevus has obtained positive data in the phase 3 clinical study Ocarina II to treat recurrent or primary progressive multiple sclerosis.
Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%
Chugai Pharmaceutical's (TYO:4519) parent company, Roche Holding, posted group sales of 14.4 billion Swiss francs for the first quarter, down 6% from 15.3 billion francs a year earlier, according to a
DZ BANK AG Sticks to Its Buy Rating for Roche Holding AG (RHHVF)
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
Wednesday, HOOKIPA Pharma Inc (NASDAQ:HOOK) received clearance from the FDA for its Investigational New Drug (IND) application for HB-700, a novel arenaviral therapeutic vaccine for the treatment of K
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Day One Biopharmaceuticals (DAWN) and Roche Holding AG (OtherRHHVF)
UBS Remains a Hold on Roche Holding AG (RHHVF)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Danaher (DHR) and Roche Holding AG (OtherRHHVF)
Roche Results, Outlook Don't Surprise -- Market Talk
0625 GMT - Roche's first-quarter sales were broadly in line with consensus with its eye drug Vabysmo as a growth driver, offset by a sales decline of its Covid-19 products, Jefferies analysts say in a
Correction to Roche Article
Sales at Roche's pharmaceutical and diagnostics divisions both fell 6%, to CHF10.92 billion and CHF3.48 billion, respectively. "Roche Sales Decline on Currency Hit," at 0534 GMT, misstated the figures
Roche Sales Decline on Currency Hit
By Helena Smolak Roche first-quarter sales declined amid weak demand for Covid-19 products and currency headwinds but slightly beat analysts expectations. The Swiss pharmaceutical giant said Wednesd
Roche Sales Decline in Last Quarter of Pandemic Impact
Roche Holding AG cut a fifth of its pipeline of experimental drugs in recent quarters as its new chief executive tries to revive growth after a series of research setbacks.
Swiss Drugmaker Roche's Q1 Sales Fall; FY24 Outlook Confirmed
Roche (RO.SW, ROG.SW) said Wednesday its sales decreased year over year in the first quarter ended March. The Swiss drugmaker's group sales stood at 14.40 billion francs, compared with 15.32 billion f
Roche Pharmaceutical Division 1Q Sales Up 2% at Constant Currency
Roche Pharmaceutical Division 1Q Sales Up 2% at Constant Currency
Roche Backs 2024 View
Roche Backs 2024 View
Roche: Results Negatively Affected by Appreciation of Swiss Franc
Roche: Results Negatively Affected by Appreciation of Swiss Franc
Analysts Saw Roche 1Q Sales at CHF14.35B
Analysts Saw Roche 1Q Sales at CHF14.35B
Analysis
Price Target
No Data
